Galectin-3 and atrial fibrillation showed an independent predictive value of composite clinical outcome of mortality, nonfatal myocardial infarction, nonfatal stroke, transient ischemic attack and/or heart failure. The gene discussed is LGALS3; the disease is transient ischemic attack.